P21Peptide.com

Why this name

Two characters and a number do a great deal of work here. P21 reads as a compound code, the kind of shorthand that appears in method sections and internal decks, and "Peptide" removes any doubt about the category. Kept singular, the name commits to one molecule rather than a catalogue, which is how serious development programs present themselves before a trade name exists.

A peptide developer, licensing group or specialty pharmaceutical company gains a permanent home for one asset: mechanism summaries, publication lists, supply enquiries, investor briefs. The .com carries weight with international partners and journalists who will type the compound code directly. Descriptive branded alternatives blur into one another; a designation this tight is remembered after a single reading and repeated correctly.

Well suited to

• Single-asset peptide development program site
• Licensing and partnering microsite
• Research-grade compound supplier storefront
• Clinical and preclinical data repository
• Scientific advisory and publications hub

Ideal owner A peptide therapeutics developer or licensor centred on one lead compound.